Anti-C1q antibodies as a follow-up marker in SLE patients

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Bock, Merete ^a   Heijnen, Ingmar ^a   Trendelenburg, Marten ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1Q ANTIBODY; CREATININE; AUTOANTIBODY; COMPLEMENT COMPONENT C1Q;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOMARKERS; COMPLEMENT C1Q; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84928138069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123572     Document Type: Article

References (33)

1. Tsokos G. (2011) Systemic lupus erythematosus. N Engl J Med 365: 2110-2121. doi: 10.1056/ NEJMra1100359 PMID: 22129255
2. Cameron J. (1999) Lupus nephritis. J Am Soc Nephrol 10: 413-424. PMID: 10215343
3. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 11:299-308.
4. Giles I, Putterman C. Autoantibodies and other biomarkers: pathological consequences (1). Lupus 2008; 17:241-6. doi: 10.1177/0961203307088248 PMID: 18372369
5. Walport MJ. Complement. Part 1. N Engl J Med 2001; 344:1058-66. PMID: 11287977
6. Walport MJ. Complement. Part 2. N Engl J Med 2001; 344:1140-4. PMID: 11297706
7. Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994; 87:455-64.
8. Pickering M., Botto M., Taylor P., Lachmann P., Walport M. (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76: 227-324. PMID: 11079100
9. Schejbel L, Skattum L, Hagelberg S, Ahlin A, Schiller B, Berg S et al. Molecular basis of hereditary C1q deficiency - revisited: identification of several novel disease-causing mutations. Genes Immun 2011; 12:626-34. doi: 10.1038/gene.2011.39 PMID: 21654842
10. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002; 4(Suppl. 3):S279-93 PMID: 12110148
11. Fremeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkin MD. 1996. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5: 216-220.
12. Trendelenburg M, Courvoisier S, Spath PJ, Moll S, Mihatsch M, Itin P, et al. 1999. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am. J. Kidney Dis. 34: 745-751. PMID: 10516358
13. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Fremeaux-Bacchi V, et al. (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dialysis Transplant 21: 3115-3121. PMID: 16877491
14. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli J. (1999) Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 42: 187-188 PMID: 9920031
15. Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations. Seminars in Arthritis and Rheumatism, vol. 41, no. 6, pp. 840-848 doi: 10.1016/j.semarthrit.2011.09.009 PMID: 22177108
16. Kozyro I, Perahud I, Sadallah S, Sukalo A, Titov L, et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics. 2006; 117:1663-1668 PMID: 16651321
17. Potlukova E., Kralikova P. (2008). Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Scand. J. Immunol. 67, 423-430. doi: 10.1111/j.1365-3083.2008.02089.x PMID: 18363591
18. Marto N, Bertolaccini ML, Calabuig E, Hughes GRV, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titers and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005; 64:444-8. PMID: 15286009
19. Horváth L, Czirják L, Fekete B, Jakab L, Pozsonyi T, Kalabay L, et al. High levels of antibodies against C1q are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001; 19:667-72. PMID: 11791638
20. Trendelenburg M. (2005). Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin. Immunopathol. 27, 276-285. doi: 10.1007/s00281-005-0007-y PMID: 16189648
21. Sinico R. A., Rimoldi L., Radice A., Bianchi L., Gallelli B., Moroni G. (2009). Anti-C1q autoantibodies in lupus nephritis. Ann. N. Y. Acad. Sci. 1173, 47-51. doi: 10.1111/j.1749-6632.2009.04746.x PMID: 19758131
22. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementamia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol. 1991; 18:230-4. PMID: 2023216
23. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis. 2009; 68:234-7. doi: 10.1136/ard.2008.094508 PMID: 18718989
24. Akhter E., Burlingame R. W., Seaman A. L., Magder L., Petri M. (2011). Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 20, 1267-1274. doi: 10.1177/0961203311411597 PMID: 21813587
25. Trendelenburg M., Lopez-Trascasa M., Potlukova E., Moll S., Regenass S., Fremeaux-Bacchi V., et al. (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dialysis Transplant 21: 3115-3121. PMID: 16877491
26. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum. 2011; 14:2436-2444. doi: 10.1002/art.30401
27. Hochberg MC: Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725. PMID: 9324033
28. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2004), The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity. Arthritis & Rheumatism, 50: 3418-3426. doi: 10.1002/art.20628
29. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992, 35:630-640. PMID: 1599520
30. Mayer M.M. 1961. Complement and complement fixation, p. 133-239. In Kabat E.A. and Mayer M.M. (ed.), Experimental Immunochemestriy, 2nd ed. Charles C. Thomas, Publisher, Springfield, III.
31. Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52:851-6. PMID: 8311534
32. Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26:595-601. PMID: 7573013
33. Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int. 1991; 11(3):101-7. PMID: 1754810